Fertility Preservation Network Launches Mobile Website

Sept. 27, 2011 - PRLog -- ReproTech, Ltd., a cryobank specializing in long-term storage of human reproductive tissue (sperm, eggs, embryos and ovarian and testicular tissue), recently launched a mobile version of its website, http://www.reprotech.com, supported by mobile devices including iPhone, BlackBerry, Android and Windows smartphones.

The mobile version allows users to view ReproTech’s educational information on Fertility Preservation, and provides links to fertility clinics in its Fertility Preservation Network that offer cryopreservation services.  The mobile site also provides information on The OverNite Male™ Kit , ReproTech’s “sperm banking by air” kit, for males who are unable to visit a fertility clinic due to illness or location.  ReproTech’s Fertility Preservation App, http://reprotech.com/cryostorage/fertility-preservation/fertility-preservation-app.html,
another focus of the mobile site, provides oncology professionals with easy to find and up to date information for their newly diagnosed cancer patients.

The App has been selected as a finalist for the Member’s Choice Award at the American Association of Tissue Banks (AATB) Annual Meeting’s Communications, Advertising and Marketing (CAM) Awards.  The App was also selected to be presented as an Electronic Poster during the 2011 Oncofertility Consortium Conference poster session.

ReproTech staff demonstrated its App and mobile website at two recent Nurse Navigator conferences, as well as distributed its Fertility Preservation 101 educational booklet and other information.

According to the American Cancer Society, 140,000 men and women of childbearing age are newly diagnosed with cancer each year. There often is a small window of time for them to preserve their fertility; therefore, access to cryopreservation services is extremely important. ReproTech’s ongoing campaign to promote Fertility Preservation awareness and education stresses the significance of healthcare providers discussing options for Fertility Preservation with patients at diagnosis. Both the American Society of Clinical Oncology (ASCO) and American Society of Reproductive Medicine (ASRM) recommend the education of oncology patients about the options available to preserve their fertility.


About ReproTech, Ltd.
ReproTech Ltd. was founded in 1990 for the purpose of providing long-term cryostorage services and now operates regional cryostorage facilities in Florida, Minnesota, and Nevada. More information on ReproTech, Ltd is available at www.reprotech.com
or 888-489-8944. Information specific to the Fertility Preservation Network and its members can be found at http://www.fertilitypreservation.com.

# # #

ReproTech has specialized in long-term cryostorage and transportation of reproductive tissues since 1990. Network members offer fertility preservation services, and Auto Transfer Management enables IVF centers to eliminate future abandoned specimens.